Drug:
Reaction: ERYTHEMA
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26926316 |
53 | 2 | |
Flushing, Fatigue, Erythema, |
||||
UBLITUXIMAB, |
||||
| 202 | 26926485 |
US |
||
Erythema, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 203 | 26928870 |
53 | 1 | |
Eye movement disorder, Salivary hypersecretion, Unresponsive to stimuli, Cardio-respiratory arrest, Tremor, Erythema, Dyspnoea, Seizure, Anaphylactic reaction, Drug hypersensitivity, Drug resistance, Catheter site discomfort, Sepsis, Escherichia infection, Urinary retention, Neurogenic bladder, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 204 | 26915119 |
BR |
2 | |
Epistaxis, Neoplasm malignant, Metastases to bone, Breast cancer, Loss of consciousness, Haemangioma, Spinal cord neoplasm, Skull fracture, Spinal cord injury, Metastasis, Metastases to central nervous system, Immunodeficiency, Brain neoplasm, Metastases to liver, Nasal dryness, Skin exfoliation, Skin fissures, Dry skin, Skin atrophy, Tumour marker abnormal, Tumour marker increased, Pain, Discomfort, Hiatus hernia, Reflux gastritis, Discouragement, Visual impairment, Movement disorder, Greater trochanteric pain syndrome, Feeding disorder, Hernia, Burning sensation, Pain of skin, Abdominal discomfort, Malaise, Hepatic lesion, White blood cell count decreased, Neutrophil count decreased, Rhinitis allergic, Sinusitis, Bowel movement irregularity, PIK3CA-activated mutation, Vein disorder, Ill-defined disorder, Pruritus, Lip dry, Erythema, Hair texture abnormal, Swelling, Atrophic vulvovaginitis, Vulvovaginal burning sensation, Vulvovaginal discomfort, Vulvovaginal dryness, Urinary tract infection, Inadequate lubrication, Device physical property issue, Clavicle fracture, Panic disorder, Oestrogen deficiency, Injury, Pain, Alopecia, Skin laceration, Haematoma, Macule, Central nervous system lesion, Vaginal disorder, Haemorrhoids, Spinal disorder, Angiopathy, Neoplasm, Haemangioma of bone, Carpal tunnel syndrome, Head discomfort, Weight decreased, Insomnia, Drug intolerance, Drug ineffective, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, EXEMESTANE, EXEMESTANE, CLONAZEPAM, FULVESTRANT, |
||||
| 205 | 26915136 |
US |
74 | 2 |
Generalised oedema, Erythema, Pruritus, Skin exfoliation, |
||||
INSULIN DEGLUDEC, |
||||
| 206 | 26915176 |
GB |
71 | 1 |
Muscle spasms, Joint swelling, Erythema, Dizziness, |
||||
AMLODIPINE, EZETIMIBE, |
||||
| 207 | 26915484 |
US |
34 | 2 |
Nasal congestion, Rhinalgia, Head discomfort, Oropharyngeal discomfort, Cough, Choking, Erythema, Wheezing, |
||||
OSELTAMIVIR PHOSPHATE, |
||||
| 208 | 26915543 |
EU |
57 | 1 |
Erythema, Oxygen saturation abnormal, Pyrexia, |
||||
| 209 | 26915566 |
US |
78 | 2 |
Skin burning sensation, Pruritus, Erythema, |
||||
ABATACEPT, BIMEKIZUMAB, |
||||
| 210 | 26915719 |
BR |
2 | |
Vulvovaginal injury, Spinal fracture, Vein rupture, Metastases to bone, Metastases to spine, Metastases to liver, Metastasis, Haemorrhage, Hydronephrosis, Urinary retention, Seizure, Breast cancer, Malignant neoplasm progression, Nail cuticle fissure, Epistaxis, Dry skin, Dry mouth, Constipation, Vulvovaginal dryness, Drug ineffective, Petechiae, Skin tightness, Visual impairment, Skin fissures, Skin atrophy, Dry throat, Nasal mucosal disorder, Rhinalgia, Secretion discharge, Insomnia, Throat irritation, Hair texture abnormal, Skin exfoliation, Breast disorder, Tumour marker increased, Calcification metastatic, Weight increased, Flatulence, Reflux gastritis, Hiatus hernia, Gastritis, Muscle spasms, Vitamin B12 deficiency, Feeding disorder, Balance disorder, Head injury, Fall, Dermal absorption impaired, Thermal burn, Nasal congestion, Eye swelling, Phlebitis, Rhinitis allergic, Allergic sinusitis, Decreased immune responsiveness, Gastric polyps, Skeletal injury, Pelvic bone injury, Epistaxis, Oropharyngeal discomfort, Hypersensitivity, Discomfort, Quality of life decreased, Rectocele, Bone lesion, Product distribution issue, Thinking abnormal, Feeling abnormal, Carbohydrate antigen 15-3 increased, PIK3CA-activated mutation, Quality of life decreased, Feeding disorder, Sensory disturbance, Skin discolouration, COVID-19, Bone pain, Condition aggravated, Anosmia, Malaise, Gene mutation, Urinary tract infection, Oral pain, Muscle injury, Hepatic mass, Dysbiosis, Oral disorder, Speech disorder, Chills, Lip swelling, Gait disturbance, Gastrointestinal disorder, Pain, Depressed mood, Myalgia, Atrophic vulvovaginitis, Nasal disorder, Head injury, Malaise, Tumour marker abnormal, Central nervous system lesion, Hepatic lesion, Cervix disorder, Uterine leiomyoma, Bacteriuria, Swelling face, Pruritus, Erythema, White blood cell count decreased, Nausea, Peripheral swelling, Vomiting, Diarrhoea, Nasopharyngitis, Dizziness, Abdominal pain upper, Cough, Retching, Fatigue, Sinusitis, Infection, Rhinitis, Abdominal pain, Dyspnoea, Abdominal discomfort, Drug resistance, Pain, Pain in extremity, Head discomfort, Decreased appetite, Vision blurred, Illness, Weight decreased, Arthralgia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PANTOPRAZOLE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALPELISIB, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, EXEMESTANE, CLONAZEPAM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ERGOCALCIFEROL, |
||||
| 211 | 26915782 |
US |
1 | |
Blindness, Erythema, Skin exfoliation, Rash, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, DUPILUMAB, |
||||
| 212 | 26915847 |
US |
38 | 2 |
Erythema, Liquid product physical issue, |
||||
| 213 | 26915915 |
IN |
84 | 2 |
Erythema, Generalised oedema, |
||||
AMLODIPINE BESYLATE, TERIPARATIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 214 | 26916030 |
EU |
60 | 1 |
Dizziness, Flushing, Erythema, |
||||
IRINOTECAN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 215 | 26916201 |
EU |
11 | 1 |
Haemolytic anaemia, Telangiectasia, Obesity, Erythema, Skin striae, |
||||
DAPSONE GEL, 5%, DAPSONE, DASPONE, METHYLPREDNISOLONE, |
||||
| 216 | 26916300 |
US |
2 | |
Eczema, Erythema, Pruritus, Inflammation, Therapeutic response decreased, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 217 | 26916320 |
US |
8 | 2 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 218 | 26916697 |
EU |
||
Cough, Chest discomfort, Erythema, Wheezing, Dyspnoea, Suspected off label use, |
||||
INFLIXIMAB, |
||||
| 219 | 26916985 |
EU |
84 | 2 |
Acute kidney injury, Erythema, Diarrhoea, |
||||
ALLOPURINOL, FENTANYL, |
||||
| 220 | 26917192 |
GB |
37 | 1 |
Heat exhaustion, Skin warm, Erythema, Chills, Blister, |
||||
OLANZAPINE, |
||||
| 221 | 26917435 |
EU |
2 | |
Dermatitis, Pruritus, Erythema, |
||||
POVIDONE-IODINE, |
||||
| 222 | 26917636 |
GB |
||
Contusion, Erythema, |
||||
MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), |
||||
| 223 | 26917825 |
|||
Joint swelling, Peripheral swelling, Pustule, Balanoposthitis, Erythema, Noninfective gingivitis, Medication error, |
||||
DAPAGLIFLOZIN, |
||||
| 224 | 26918066 |
US |
70 | 2 |
Peripheral swelling, Eczema, Erythema, |
||||
DUPILUMAB, DUPILUMAB, RISANKIZUMAB-RZAA, |
||||
| 225 | 26918174 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 226 | 26918213 |
BR |
56 | 2 |
Dysentery, Lung cancer metastatic, Second primary malignancy, Blood glucose abnormal, Paraesthesia, Skin disorder, Feeding disorder, Arthropathy, Skin exfoliation, Liver disorder, Weight increased, Hypotonia, Weight decreased, Diarrhoea, Dry skin, Rash, Diarrhoea, Mucosal dryness, Aphthous ulcer, Pruritus, Blood glucose increased, Mucosal inflammation, Hepatic enzyme abnormal, Malaise, Nutritional condition abnormal, Liver function test abnormal, Skin discolouration, Glossodynia, Gingival erythema, Bradykinesia, Hypotension, Gastrointestinal disorder, Muscle atrophy, Visual impairment, Memory impairment, Anxiety, Abdominal discomfort, Adverse reaction, Hormone level abnormal, Illness, COVID-19, Dysarthria, Dyspnoea, Blood glucose increased, Erythema, Gingival pain, Fatigue, Abdominal pain upper, Myalgia, Arthralgia, Lung disorder, Posture abnormal, |
||||
FULVESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, ALPELISIB, |
||||
| 227 | 26918264 |
US |
2 | 1 |
Dry skin, Erythema, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 228 | 26918427 |
US |
2 | |
Arthralgia, Arthritis, Erythema, Peripheral swelling, Drug hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 229 | 26918497 |
74 | ||
Erythema, Eyelid pain, Eyelids pruritus, Skin burning sensation, Rash pruritic, |
||||
BUMETANIDE, ATENOLOL, ENALAPRIL, OMEPRAZOLE MAGNESIUM, |
||||
| 230 | 26918609 |
US |
16 | 1 |
Depressed level of consciousness, Flushing, Muscular weakness, Erythema, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE, |
||||
| 231 | 26918750 |
CN |
64 | 2 |
Hypotension, Palpitations, Anosmia, Urinary incontinence, Hypoaesthesia oral, Contusion, Dizziness, Nausea, Vomiting, Diarrhoea, Ageusia, Paraesthesia, Erythema, |
||||
PRALSETINIB, |
||||
| 232 | 26918797 |
EU |
54 | 2 |
Renal failure, Rash maculo-papular, Urticaria, Eosinophilia, Erythema, |
||||
CLINDAMYCIN HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 233 | 26918833 |
BR |
69 | 2 |
Death, Skin exfoliation, Erythema, Pigmentation disorder, |
||||
PANITUMUMAB, |
||||
| 234 | 26918974 |
US |
50 | 2 |
Rash, Erythema, Dry skin, Skin fissures, Dry mouth, |
||||
NIVOLUMAB, CABOZANTINIB, |
||||
| 235 | 26919610 |
US |
2 | |
Erythema, Rash, Pruritus, |
||||
| 236 | 26919745 |
US |
57 | 2 |
Erythema, Rash, Eye irritation, Drug ineffective, |
||||
ACOLTREMON, FREMANEZUMAB-VFRM, BELIMUMAB, BUPROPION HYDROCHLORIDE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, TIZANIDINE, |
||||
| 237 | 26920269 |
US |
80 | 2 |
Hypersensitivity, Pruritus, Erythema, |
||||
ACOLTREMON, BIOTIN, CALCIUM, ROSUVASTATIN, LENALIDOMIDE, ESCITALOPRAM, PREGABALIN, MAGNESIUM, PANTOPRAZOLE SODIUM, LEVOTHYROXINE SODIUM, RIVAROXABAN, ACYCLOVIR, |
||||
| 238 | 26920369 |
US |
78 | 2 |
Erythema, Nausea, |
||||
ACOLTREMON, BIOTIN, CALCIUM, EZETIMIBE, MAGNESIUM, TELMISARTAN, VITAMIN C, |
||||
| 239 | 26920371 |
US |
2 | |
Erythema, Rash pruritic, Hypersensitivity, Product administration interrupted, |
||||
ACOLTREMON, CARVEDILOL, FOLIC ACID, LETROZOLE, LETROZOLE TABLETS, LOSARTAN, PANTOPRAZOLE, ZOLEDRONIC ACID, CYCLOSPORINE, SELPERCATINIB, EZETIMIBE, ASPIRIN, ASPIRIN 81 MG DELAYED RELEASE TABLETS, |
||||
| 240 | 26920441 |
US |
2 | |
Pruritus, Erythema, Ocular hyperaemia, Skin exfoliation, |
||||
ACOLTREMON, BIOTIN, BUPROPION, CELECOXIB, FUROSEMIDE, GABAPENTIN, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PHENTERMINE HYDROCHLORIDE, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 241 | 26921000 |
EU |
74 | 1 |
Hyperpyrexia, Erythema, |
||||
BEVACIZUMAB, CISPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 242 | 26921012 |
64 | 1 | |
Erythema, Skin injury, Injection site discharge, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 243 | 26921172 |
EU |
75 | 2 |
Dehydration, Urine output decreased, Pruritus, Pruritus, Pruritus, Pruritus, Erythema, Erythema, Erythema, Pruritus, |
||||
FLUOXETINE HYDROCHLORIDE, |
||||
| 244 | 26921248 |
EU |
41 | 2 |
Initial insomnia, Arrhythmia, Pruritus, Partial seizures, Erythema, Cystitis, Cytokine storm, Multiple sclerosis, Cardiac disorder, Headache, Swelling of nose, Hypoaesthesia, Pain of skin, Tachycardia, Oral candidiasis, Fatigue, Influenza like illness, B-lymphocyte count decreased, Inflammatory marker increased, Weight decreased, Muscle spasticity, Electrocardiogram abnormal, Oropharyngeal pain, Fall, Muscular weakness, Hyperacusis, Gait disturbance, Cognitive disorder, Middle insomnia, Skin burning sensation, Urinary tract infection, Pain in extremity, Off label use, Suspected off label use, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, OCRELIZUMAB, OCRELIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BUDESONIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TIZANIDINE HYDROCHLORIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, FOLIC ACID, DRONABINOL, LEVETIRACETAM, |
||||
| 245 | 26923479 |
47 | 2 | |
Flushing, Chest discomfort, Erythema, Erythema, Infusion related reaction, |
||||
FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, |
||||
| 246 | 26909565 |
US |
32 | 2 |
Constipation, Gastrointestinal pain, Vulvovaginal burning sensation, Erythema, Impaired work ability, Influenza like illness, Insomnia, Hypersensitivity, Dizziness, Fatigue, Myalgia, Body temperature increased, Hyperhidrosis, Urticaria, Rash, Pruritus, Nausea, Abdominal pain, Wrong technique in product usage process, |
||||
TIOPRONIN, POTASSIUM CITRATE, |
||||
| 247 | 26909813 |
US |
2 | |
Pain in extremity, Erythema, Peripheral swelling, Migraine, Diarrhoea, Platelet count decreased, Therapy non-responder, |
||||
TREPROSTINIL, TREPROSTINIL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, SOTATERCEPT-CSRK, FUROSEMIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, |
||||
| 248 | 26909856 |
EU |
2 | |
Erythema, Skin exfoliation, Pustule, |
||||
PANITUMUMAB, |
||||
| 249 | 26909881 |
US |
2 | |
Skin swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 250 | 26910130 |
CA |
2 | |
Cerebrovascular accident, Fall, Cerebrovascular accident, Pneumonia, Fall, Hypovolaemia, Peripheral swelling, Malaise, Diarrhoea, Abdominal discomfort, Fatigue, Arthropod bite, Joint swelling, Erythema, Nausea, Hypertension, Wrist fracture, Rib fracture, Head injury, Suicide attempt, Bronchitis, Productive cough, Unresponsive to stimuli, Malignant neoplasm progression, Suicidal ideation, Vasculitis, Depression, Depressed mood, Nervousness, Nervousness, Psychiatric symptom, Blood pressure increased, Depression, Tremor, Feeling jittery, Pain in extremity, Wound, Cough, Muscular weakness, Pollakiuria, Nasopharyngitis, Gait disturbance, Hypoacusis, Nervousness, Screaming, Contusion, Emotional distress, Anger, Crying, Mental disorder, Anxiety, Headache, Rash, Feeling abnormal, Inappropriate schedule of product administration, |
||||
AMLODIPINE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, GABAPENTIN, OLANZAPINE, PRUCALOPRIDE SUCCINATE, PREDNISONE, ERGOCALCIFEROL, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CALCIUM CARBONATE, ANTACID, PANTOPRAZOLE, |
||||
| 251 | 26910334 |
US |
1 | |
Erythema, Pruritus, Skin burning sensation, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 252 | 26910450 |
EU |
49 | 1 |
Erythema, Skin lesion, Feeling hot, Throat tightness, Dyspnoea, |
||||
INFLIXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 253 | 26910521 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 254 | 26910951 |
US |
73 | |
Eczema nummular, Erythema, Skin exfoliation, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 255 | 26911105 |
US |
1 | |
Dermatitis contact, Erythema, Pruritus, |
||||
DUPILUMAB, DESONIDE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 256 | 26911549 |
US |
2 | |
Erythema, |
||||
DUPILUMAB, |
||||
| 257 | 26911919 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 258 | 26912006 |
US |
2 | |
Impaired driving ability, Erythema, Skin exfoliation, Rash, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 259 | 26912394 |
US |
2 | |
Pyrexia, Skin mass, Pain, Erythema, Rash, |
||||
DUPILUMAB, ERGOCALCIFEROL, FAMOTIDINE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 260 | 26912400 |
US |
61 | 2 |
Erythema, Skin warm, Skin discolouration, Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
| 261 | 26912615 |
EU |
31 | 2 |
General physical health deterioration, Hyperthermia, Myalgia, Erythema, Vision blurred, Conjunctival hyperaemia, |
||||
RITLECITINIB, RITLECITINIB, RITLECITINIB, |
||||
| 262 | 26912687 |
EU |
2 | |
Syncope, Atrioventricular block, Lymphoedema, Injection site bruising, Head injury, Arthralgia, Tachycardia, Cardiac pacemaker insertion, Musculoskeletal discomfort, Bone pain, Dizziness, Wound, Feeling abnormal, Injection site discomfort, Erythema, Urinary tract infection, Injection site pain, Pruritus, Pyrexia, Headache, Somnolence, Chromaturia, Rhinalgia, |
||||
ROZANOLIXIZUMAB, ROZANOLIXIZUMAB, DAPAGLIFLOZIN, FUROSEMIDE, ERGOCALCIFEROL, IRBESARTAN, EVOLOCUMAB, PYRIDOSTIGMINE BROMIDE, |
||||
| 263 | 26913011 |
EU |
58 | 2 |
Extravasation, Oedema, Erythema, Induration, Skin discolouration, |
||||
NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, PROPOFOL, PROPOFOL, PROPOFOL, PROPOFOL, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ROCURONIUM BROMIDE, ROCURONIUM BROMIDE, ROCURONIUM BROMIDE, ROCURONIUM BROMIDE, |
||||
| 264 | 26913601 |
US |
1 | |
Flushing, Erythema, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 265 | 26913769 |
BR |
63 | 2 |
Acute myeloid leukaemia, Second primary malignancy, Septic shock, Somnolence, Pyrexia, Hypotension, Chills, Dyspnoea, Multiple organ dysfunction syndrome, Nervous system disorder, Cardiovascular disorder, Renal impairment, Hepatic function abnormal, Neutrophil count decreased, Cytokine release syndrome, Pyrexia, Hypotension, Febrile neutropenia, Febrile neutropenia, Pyrexia, Leukopenia, Haemoglobin decreased, Thrombocytopenia, Pneumonia, Skin reaction, Wheezing, Haemorrhage, Cough, Hyperaemia, Pruritus, Purpura, Contusion, Pancytopenia, Platelet count decreased, Lymphocyte count decreased, Vitreous haemorrhage, Acute kidney injury, Blood alkaline phosphatase increased, Blood urea increased, Eosinophil count decreased, Monocyte count decreased, White blood cell count decreased, Serum ferritin increased, Fibrin D dimer increased, Nausea, Vomiting, Pain in extremity, Tremor, Somnolence, Constipation, Fatigue, Oedema peripheral, Gingival bleeding, Hepatic mass, Odynophagia, Back pain, Erythema, Petechiae, Asthenia, Headache, Epistaxis, Pain in extremity, Paraesthesia, Pain in extremity, Dry mouth, |
||||
TISAGENLECLEUCEL, CEFEPIME HYDROCHLORIDE, CEFEPIME, MEROPENEM, |
||||
| 266 | 26913858 |
US |
30 | 1 |
Arthralgia, Insomnia, Joint stiffness, Erythema, Alopecia, |
||||
SIBEPRENLIMAB, BUDESONIDE, BUDESONIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ATENOLOL, |
||||
| 267 | 26913872 |
US |
59 | 2 |
Injury, Erythema, Eye contusion, Bleeding time prolonged, Eye pain, Generalised oedema, |
||||
SIBEPRENLIMAB, |
||||
| 268 | 26914018 |
US |
55 | 1 |
Injection site pain, Product preparation issue, Pruritus, Erythema, Condition aggravated, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 269 | 26914043 |
US |
76 | 2 |
Pruritus, Swelling face, Peripheral swelling, Erythema, Hypersensitivity, |
||||
SIBEPRENLIMAB, |
||||
| 270 | 26914078 |
EU |
74 | 1 |
Hyperpyrexia, Erythema, |
||||
BEVACIZUMAB, CISPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 271 | 26914158 |
US |
1 | |
Erythema, Pruritus, Swelling face, Skin exfoliation, |
||||
SIBEPRENLIMAB, BUDESONIDE, BUDESONIDE, BUDESONIDE, |
||||
| 272 | 26914202 |
US |
2 | |
Erythema, Pruritus, Eyelid margin crusting, Periorbital swelling, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
| 273 | 26914226 |
EU |
20 | 1 |
Oedema, Erythema, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 274 | 26914394 |
US |
||
Erythema, Nausea, |
||||
DONANEMAB-AZBT, DONANEMAB-AZBT, |
||||
| 275 | 26917344 |
67 | 2 | |
Alopecia, Erythema, Pruritus, |
||||
ROSUVASTATIN CALCIUM, |
||||
| 276 | 26917706 |
57 | 2 | |
Burning sensation, Erythema, Scab, Skin induration, Skin mass, Skin discolouration, Skin infection, Post procedural infection, Product information content complaint, Pruritus, |
||||
MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MUPIROCIN, MUPIROCIN CALCIUM, AMOXICILLIN AND CLAVULANATE POTASSIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ERGOCALCIFEROL, MAGNESIUM, |
||||
| 277 | 26904557 |
US |
74 | 2 |
Pruritus, Eye pruritus, Erythema, Swelling, |
||||
DENOSUMAB, |
||||
| 278 | 26904773 |
EU |
82 | 2 |
C-reactive protein abnormal, Peripheral swelling, Inflammation, Erythema, Joint swelling, Pyrexia, Swelling, |
||||
CEPHALEXIN, |
||||
| 279 | 26905279 |
CA |
46 | |
Chest discomfort, Wheezing, Dyspnoea, Weight decreased, Harvey-Bradshaw index increased, Migraine, Oropharyngeal discomfort, Cough, Erythema, Dizziness, Intentional product use issue, Off label use, Inappropriate schedule of product administration, Product dose omission issue, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 280 | 26905362 |
US |
3 | 2 |
Dermatitis atopic, Skin fissures, Erythema, Skin exfoliation, |
||||
DUPILUMAB, MONTELUKAST SODIUM, |
||||
| 281 | 26905366 |
US |
1 | |
Pain of skin, Erythema, Skin swelling, Rash pustular, |
||||
DUPILUMAB, |
||||
| 282 | 26905410 |
JP |
2 | |
SJS-TEN overlap, Corneal opacity, Corneal neovascularisation, Oropharyngeal pain, Lip erosion, Conjunctival hyperaemia, Erythema, Pyrexia, Oral mucosa erosion, Vulval ulceration, Lymph node pain, Lymphadenopathy, Malaise, Skin erosion, Papule, Pruritus, Blister, Skin exfoliation, Conjunctivitis, Eye oedema, Eye discharge, Conjunctival scar, Visual acuity reduced, Genital scarring, Vaginal stricture, Product use in unapproved indication, Off label use, |
||||
LAMOTRIGINE, CEFDINIR, |
||||
| 283 | 26905534 |
US |
61 | 1 |
Fatigue, Dry skin, Hypertension, Rash, Erythema, |
||||
NIVOLUMAB, CABOZANTINIB, RIVAROXABAN, AMLODIPINE, ATENOLOL, LORAZEPAM, LOSARTAN POTASSIUM, LOSARTAN, METHOCARBAMOL, METHOCARBAMOL TABLETS, |
||||
| 284 | 26905568 |
2 | ||
Death, Skin lesion, Application site pain, Inappropriate schedule of product administration, Off label use, Application site swelling, Erythema, |
||||
MECHLORETHAMINE HYDROCHLORIDE, |
||||
| 285 | 26905621 |
US |
7 | 1 |
Eczema, Erythema, Pruritus, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 286 | 26905784 |
CO |
77 | 2 |
Blindness, Deafness, Chest injury, Fall, Viral infection, Back injury, Facial pain, Joint swelling, Influenza, Pain, Arthralgia, Plantar fasciitis, Gastrooesophageal reflux disease, Illness, Abdominal discomfort, Dizziness, Erythema, Burning sensation, Rash, Ocular icterus, Lacrimation increased, Photophobia, Headache, Gingival pain, Amnesia, Alopecia, Odynophagia, Facial asymmetry, Rhinorrhoea, Gait disturbance, Depression, Skin exfoliation, Coordination abnormal, |
||||
DENOSUMAB, |
||||
| 287 | 26905993 |
US |
2 | |
Skin ulcer, Hypersensitivity, Pyrexia, Hyperhidrosis, Dyspnoea, Fatigue, Pain, Skin warm, Erythema, Pain of skin, Cough, Haemoptysis, Diarrhoea, Abdominal pain upper, Dysuria, Weight decreased, Drug ineffective, Memory impairment, |
||||
DUPILUMAB, PREDNISONE, ERGOCALCIFEROL, |
||||
| 288 | 26906117 |
US |
||
Rash pruritic, Skin exfoliation, Skin burning sensation, Hepatic enzyme increased, Erythema, |
||||
UPADACITINIB, |
||||
| 289 | 26906352 |
US |
1 | |
Dermatitis atopic, Erythema, Swelling face, Inappropriate schedule of product administration, |
||||
DUPILUMAB, BETAMETHASONE DIPROPIONATE, |
||||
| 290 | 26906394 |
US |
83 | 2 |
Erythema, Peripheral swelling, Varicose vein, Palmar erythema, Vein disorder, |
||||
EXEMESTANE, |
||||
| 291 | 26906483 |
EU |
67 | 2 |
Swelling face, Skin disorder, Rash, Alopecia, Erythema, |
||||
| 292 | 26906500 |
CO |
77 | 2 |
Memory impairment, COVID-19, Headache, Anxiety, Blister, Gastroenteritis viral, Psychiatric symptom, Pruritus, Urticaria, Illness, Bone disorder, Malaise, Cough, Gastrooesophageal reflux disease, Fall, Gait disturbance, Erythema, Dry skin, Angioedema, Swelling face, Peripheral swelling, Dyspnoea, Fatigue, Back pain, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FEXOFENADINE, |
||||
| 293 | 26906505 |
US |
2 | |
Injection site swelling, Erythema, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 294 | 26906706 |
EU |
2 | |
Hypokinesia, Vital functions abnormal, Brief resolved unexplained event, Erythema, Incorrect dose administered, |
||||
NIRSEVIMAB, |
||||
| 295 | 26906724 |
AU |
30 | 1 |
Ocular surface disease, Pruritus, Skin exfoliation, Eczema eyelids, Conjunctivitis, Keratitis, Dermatitis contact, Erythema, Unmasking of previously unidentified disease, |
||||
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 296 | 26907292 |
AU |
||
Erythema, Swelling, Thrombophlebitis, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 297 | 26907464 |
US |
73 | 1 |
Erythema, Product physical issue, |
||||
PANCRELIPASE, |
||||
| 298 | 26907950 |
US |
||
Hyperhidrosis, Feeling hot, Migraine, Fatigue, Erythema, Dizziness, Drug ineffective, |
||||
MIDODRINE HYDROCHLORIDE, |
||||
| 299 | 26908114 |
EU |
61 | 2 |
Syncope, Erythema, |
||||
LORAZEPAM, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 300 | 26908203 |
CN |
34 | 2 |
Rash, Erythema, Generalised oedema, Pain, Pruritus, Oral mucosal blistering, Oral mucosa erosion, Trismus, Dry skin, Swelling face, Peripheral swelling, Skin exfoliation, Pigmentation disorder, Off label use, |
||||
CARBAMAZEPINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
